← 홈

폐암 (NSCLC)

300개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 300개
AntibodystaleRochePhase 2

Belinostat, carboplatin, paclitaxel and bevacizumab (Belinostat, carboplatin, paclitaxel and bevacizumab)

Non-Small-Cell Lung Carcinoma · Non-Small-Cell Lung Carcinoma

#Non-Small-CellLungCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleXinqiao Hospital of ChongqingPhase 2

Benmelstobart combined with Bevacizumab and chemotherapy (Benmelstobart combined with Bevacizumab and chemotherapy)

NSCLC Stage IV Without EGFR/ALK Mutation · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleNational Cancer Center, KoreaPhase 2

nivolumab (Opdivo, CA and Nivolumab)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleGuangzhou Yiyang Biological Tec…Phase 1

CAR-T cells to treat advanced lung cancer (CAR-T cells to treat advanced lung cancer)

Advanced Lung Cancer · Advanced Lung Cancer

#AdvancedLungCancer#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 DISCONTINUED
CGTBiologicstaleGuangzhou Anjie Biomedical Tech…Phase 2

CAR-T combining PD-1 Knockout (CAR-T combining PD-1 Knockout)

Lung Neoplasm Malignant; Non-small Cell Lung Cancer · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleKite, A Gilead CompanyPhase 1

CART-TnMUC1 (CART-TnMUC1)

Non-Small Cell Lung Cancer; Ovarian Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
AntibodystaleGerman Cancer Research CenterPhase 2

CC-1 and Toczilizumab (CC-1 and Toczilizumab)

Lung Cancer Squamous Cell · Lung Cancer Squamous Cell

#LungCancerSquamousCell#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 2

CEA CAR-T cells (CEA CAR-T cells)

Solid Tumor; Lung Cancer · CEA

#CEA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
AntibodystaleFamewave Ltd.Phase 2

nivolumab (Opdivo, CM-24, Nivolumab, Nab paclitaxel and Gemcitabine - Expansion)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleFamewave Ltd.Phase 2

nivolumab (Opdivo, CM-24, Nivolumab, and Nal-IRI/5-FU/LV - Expansion)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleCorvus Pharmaceuticals, Inc.Phase 1

pembrolizumab (Keytruda, CPI-006 + pembrolizumab)

Non-Small Cell Lung Cancer; Renal Cell Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
ADCBiologicstaleConjupro Biotherapeutics, Inc.Phase 1

CPO301 (CPO301)

Cancer; Cancer, Lung · Cancer

#Cancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleIntergroupe Francophone de Canc…Phase 2

durvalumab (Imfinzi, Carboplatin + Paclitaxel + Durvalumab)

Small Cell Lung Cancer Extensive Stage · Small Cell Lung Cancer Extensive Stage

#SmallCellLungCancerExtensiveStag#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleCentre Francois BaclessePhase 2

atezolizumab (Tecentriq, Carboplatin + Pemetrexed + Atezolizumab)

NSCLC Stage IIIB; NSCLC Stage IV · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4
효능 ORR 64.6%임상시험 1상태 ACTIVE
AntibodystaleCentre Francois BaclessePhase 2

atezolizumab (Tecentriq, Carboplatin + Pemetrexed + Atezolizumab + Bevacizumab)

NSCLC Stage IIIB; NSCLC Stage IV · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4
효능 ORR 42.9%임상시험 1상태 ACTIVE
AntibodystaleVerastem, Inc.Phase 2

pembrolizumab (Keytruda, Carboplatin + Pemetrexed + Pembrolizumab)

Pancreatic Ductal Adenocarcinoma; Non Small Cell Lung Cancer · Pancreatic Ductal Adenocarcinoma

#PancreaticDuctalAdenocarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleImmunityBio, Inc.Phase 3

atezolizumab (Tecentriq, Carboplatin and nab-paclitaxel plus atezolizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleImmunityBio, Inc.Phase 3

atezolizumab (Tecentriq, Carboplatin and paclitaxel plus atezolizumab and bevacizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePreclinical

atezolizumab (Tecentriq, Carboplatin/Cisplatin -Etoposide - Atezolizumab)

Small Cell Lung Cancer; Large Cell Neuroendocrine (NE) Tumors · Small Cell Lung Cancer

#SmallCellLungCancer#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleImmunityBio, Inc.Phase 3

atezolizumab (Tecentriq, Cisplatin/carboplatin and pemetrexed plus atezolizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED

9 / 15 페이지

← 이전다음 →